Treatment in the STAMPEDE era for castrate resistant prostate cancer in the UK: ongoing challenges and underappreciated clinical problems

Greasley, R.U., Turner, R., Collins, K. et al. (3 more authors) (2018) Treatment in the STAMPEDE era for castrate resistant prostate cancer in the UK: ongoing challenges and underappreciated clinical problems. BMC Cancer, 18 (1). 667. ISSN 1471-2407

Abstract

Metadata

Item Type: Article
Authors/Creators:
  • Greasley, R.U.
  • Turner, R.
  • Collins, K.
  • Brown, J.
  • Bourke, L.
  • Rosario, D.J.
Copyright, Publisher and Additional Information:

© 2018 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Keywords: Castrate Resistant Prostate Cancer (CRPC); CHAARTED Trial; Health Care Professionals (HCPs); Side Ef Fects; Care Pathway
Dates:
  • Accepted: 18 May 2018
  • Published (online): 19 June 2018
  • Published: December 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 06 Jul 2018 15:54
Last Modified: 17 Apr 2024 13:42
Status: Published
Publisher: BioMed Central
Refereed: Yes
Identification Number: https://doi.org/10.1186/s12885-018-4527-y
Related URLs:

Export

Statistics